Home/Filings/4/0001641172-25-002302
4//SEC Filing

Yen Yun 4

Accession 0001641172-25-002302

CIK 0001335105other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 10:36 AM ET

Size

17.9 KB

Accession

0001641172-25-002302

Insider Transaction Report

Form 4
Period: 2025-03-31
Yen Yun
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2025-03-31+8,7778,777 total
    Exercise: $1.21From: 2025-03-31Exp: 2030-03-31Common (8,777 underlying)
Holdings
  • Options to Purchase Common Stock

    Exercise: $2.37From: 2024-06-30Exp: 2029-06-30Common (10,000 underlying)
    10,000
  • Options to Purchase Common Stock

    Exercise: $32.10From: 2021-01-06Exp: 2026-01-06Common (5,000 underlying)
    5,000
  • Options to Purchase Common Stock

    Exercise: $30.30From: 2021-06-30Exp: 2026-06-30Common (10,000 underlying)
    10,000
  • Options to Purchase Common Stock

    Exercise: $66.00From: 2019-05-22Exp: 2024-05-22Common (833 underlying)
    833
  • Options to Purchase Common Stock

    Exercise: $2.33From: 2025-01-20Exp: 2030-01-20Common (4,545 underlying)
    4,545
  • Options to Purchase Common Stock

    Exercise: $1.30From: 2024-09-30Exp: 2029-09-30Common (5,786 underlying)
    5,786
  • Options to Purchase Common Stock

    Exercise: $2.37From: 2024-06-30Exp: 2029-06-30Common (4,527 underlying)
    4,527
  • Warrants to Purchase Common Stock

    (indirect: By Sino-American Cancer FDD)
    Exercise: $57.00From: 2020-11-30Exp: 2025-11-30Common (5,263 underlying)
    5,263
  • Options to Purchase Common Stock

    Exercise: $7.45From: 2022-06-30Exp: 2027-06-30Common (10,000 underlying)
    10,000
  • Options to Purchase Common Stock

    Exercise: $16.80From: 2018-08-04Exp: 2023-08-04Common (3,333 underlying)
    3,333
Footnotes (1)
  • [F1]Effective March 31, 2025, the reporting person was granted stock options to purchase an aggregate of 8,777 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.

Documents

1 file

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

Entity typeother

Related Parties

1
  • filerCIK 0001684584

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 10:36 AM ET
Size
17.9 KB